These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 19836610)

  • 1. Insulin-like growth factor-1 (IGF-1): relation with cognitive functioning and neuroimaging marker of brain damage in a sample of hypertensive elderly subjects.
    Angelini A; Bendini C; Neviani F; Bergamini L; Manni B; Trenti T; Rovati R; Neri M
    Arch Gerontol Geriatr; 2009; 49 Suppl 1():5-12. PubMed ID: 19836610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective study on circulating insulin-like growth factor I (IGF-I), IGF-binding proteins, and cognitive function in the elderly.
    Kalmijn S; Janssen JA; Pols HA; Lamberts SW; Breteler MM
    J Clin Endocrinol Metab; 2000 Dec; 85(12):4551-5. PubMed ID: 11134107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relation between insulin-like growth factor I levels and cognition in healthy elderly: a meta-analysis.
    Arwert LI; Deijen JB; Drent ML
    Growth Horm IGF Res; 2005 Dec; 15(6):416-22. PubMed ID: 16256385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-like growth factor I (IGF-I) and cognitive decline in older persons.
    Dik MG; Pluijm SM; Jonker C; Deeg DJ; Lomecky MZ; Lips P
    Neurobiol Aging; 2003; 24(4):573-81. PubMed ID: 12714114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of IGF-I, IGF-II, and IGFBP-3 in male cognitive aging and dementia risk: the Caerphilly Prospective Study.
    Green CJ; Holly JM; Bayer A; Fish M; Ebrahim S; Gallacher J; Ben-Shlomo Y
    J Alzheimers Dis; 2014; 41(3):867-75. PubMed ID: 24705546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of insulin-like growth factor-1 and hepatocyte growth factor on carotid atherosclerosis and cognitive function in the elderly.
    Watanabe T; Yamamoto H; Idei T; Iguchi T; Katagiri T
    Dement Geriatr Cogn Disord; 2004; 18(1):67-74. PubMed ID: 15087580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Free insulin-like growth factor-I and cognitive function in older persons living in community.
    Landi F; Capoluongo E; Russo A; Onder G; Cesari M; Lulli P; Minucci A; Pahor M; Zuppi C; Bernabei R
    Growth Horm IGF Res; 2007 Feb; 17(1):58-66. PubMed ID: 17208483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased Serum Level of IGF-1 Correlates With Better Cognitive Status in End-Stage Renal Disease Patients Undergoing Hemodialysis.
    Prelevic V; Radunovic D; Antunovic T; Ratkovic M; Gligorovic-Bahranovic N; Gledovic B; Vujosevic S; Nedovic-Vukovic M; Basic-Jukic N
    Ther Apher Dial; 2018 Apr; 22(2):118-123. PubMed ID: 29214734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin-like Growth Factor 1 (IGF-1) as a marker of cognitive decline in normal ageing: A review.
    Frater J; Lie D; Bartlett P; McGrath JJ
    Ageing Res Rev; 2018 Mar; 42():14-27. PubMed ID: 29233786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic insulin-like growth factor-I administration prevents cognitive impairment in diabetic rats, and brain IGF regulates learning/memory in normal adult rats.
    Lupien SB; Bluhm EJ; Ishii DN
    J Neurosci Res; 2003 Nov; 74(4):512-23. PubMed ID: 14598295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Higher serum insulin-like growth factor-1 is associated with better cognitive performance in persons with mild cognitive impairment.
    Calvo D; Gunstad J; Miller LA; Glickman E; Spitznagel MB
    Psychogeriatrics; 2013 Sep; 13(3):170-4. PubMed ID: 25913765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating insulin-like growth factor I and cognitive function: neuromodulation throughout the lifespan.
    Aleman A; Torres-Alemán I
    Prog Neurobiol; 2009 Nov; 89(3):256-65. PubMed ID: 19665513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebral blood flow measurement by PET in hypertensive subjects as a marker of cognitive decline.
    Kitagawa K
    J Alzheimers Dis; 2010; 20(3):855-9. PubMed ID: 20182039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accurate prediction of histologically confirmed Alzheimer's disease and the differential diagnosis of dementia: the use of NINCDS-ADRDA and DSM-III-R criteria, SPECT, X-ray CT, and APO E4 medial temporal lobe dementias. The Oxford Project to Investigate Memory and Aging.
    Jobst KA; Barnetson LP; Shepstone BJ
    Int Psychogeriatr; 1997; 9 Suppl 1():191-222; discussion 247-52. PubMed ID: 9447442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between IGF-I concentration, cognitive function and quality of life in adults with Prader-Willi syndrome.
    van Nieuwpoort IC; Deijen JB; Curfs LM; Drent ML
    Horm Behav; 2011 Apr; 59(4):444-50. PubMed ID: 21223969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma Pentraxin 3, but not high-sensitivity C-reactive protein, is a useful inflammatory biomarker for predicting cognitive impairment in elderly hypertensive patients.
    Yano Y; Matsuda S; Hatakeyama K; Sato Y; Imamura T; Shimada K; Kodama T; Kario K; Asada Y
    J Gerontol A Biol Sci Med Sci; 2010 May; 65(5):547-52. PubMed ID: 20203097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroimaging determinants of cognitive performances in stroke associated with small vessel disease.
    Mok V; Chang C; Wong A; Lam WW; Richards PS; Wong KT; Wong KS
    J Neuroimaging; 2005 Apr; 15(2):129-37. PubMed ID: 15746224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin-like growth factor-1 predicts cognitive functions at 2-year follow-up in early, drug-naïve Parkinson's disease.
    Pellecchia MT; Santangelo G; Picillo M; Pivonello R; Longo K; Pivonello C; Vitale C; Amboni M; De Rosa A; Moccia M; Erro R; De Michele G; Santoro L; Colao A; Barone P
    Eur J Neurol; 2014 May; 21(5):802-7. PubMed ID: 23551560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-like growth factor-I, cognition and brain aging.
    van Dam PS; Aleman A
    Eur J Pharmacol; 2004 Apr; 490(1-3):87-95. PubMed ID: 15094076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-like growth factor-I and insulin-like growth factor binding protein-3 in Alzheimer's disease.
    Duron E; Funalot B; Brunel N; Coste J; Quinquis L; Viollet C; Belmin J; Jouanny P; Pasquier F; Treluyer JM; Epelbaum J; le Bouc Y; Hanon O
    J Clin Endocrinol Metab; 2012 Dec; 97(12):4673-81. PubMed ID: 23015654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.